Ethics and Policy in the Age of Genetics and Medicine
A presentation sponsored by the UC College of Medicine entitled Ethics and Policy in the Age of Genetics and Medicine will be given by Eric M. Meslin, PhD, director of the Indiana University Center for Bioethics, on Thursday, March 20, from 4-5 p.m. in Kresge Auditorium, UC College of Medicine Medical Sciences Building. Dr. Meslin is also a professor of medicine and molecular genetics at the Indiana University School of Medicine, and a professor of philosophy at the Indiana University School of Liberal Arts. He is also assistant dean for bioethics at the Indiana University School of Medicine.
Dr. Meslin came to Indiana University in July 2001 from the National Bioethics Advisory Commission (NBAC), where he had been executive director since 1998. NBAC was appointed by President Bill Clinton in 1995, and was charged with advising the White House and the federal government on a range of bioethics issues including cloning, stem cell research, international clinical trials, and genetic studies. Dr. Meslin received his PhD from the Bioethics Program in Philosophy at the Kennedy Institute of Ethics, Georgetown University in Washington, DC.
He has held academic positions at the University of Toronto and the University of Oxford. From 1996-98 he was program director for Bioethics Research in the Ethical, Legal, and Social Implications Research Program at the National Human Genome Research Institute in Bethesda, MD. He has been a consultant to the World Health Organization and he is co-editor of the Bioethics and Humanities Series published by Indiana University Press, and associate editor of the
Journal of Medical Ethics.
Dr. Meslin has authored or co-authored more than 75 articles and book chapters, including more than 30 publications in peer-reviewed literature, with most focusing on various topics in research ethics, clinical ethics, and health policy. This presentation is free and open to the public.
Related Stories
Imaging reveals how a tumor-fighting drug triggers cellular breakdown
August 24, 2026
Optics trade publication SPIE highlighted research led by the University of Cincinnati's Jiajie Diao, PhD, published in Biophotonics Discovery that demonstrated how super-resolution microscopy can track how a drug alters several important structures within cancer cells.
A new year, a shared purpose: President Pinto welcomes Bearcats to UC’s 208th fall
August 24, 2026
President Neville G. Pinto welcomes students, faculty and staff back to UC's 208th academic year.
Back to School 2026: UC remains a destination campus
August 24, 2026
The University of Cincinnati welcomes its largest first-year class and a record share of first-generation students for fall 2026, reinforced by affordability initiatives, co-op opportunities and new academic offerings across all campuses.